May 9, 2024

The House Ways and Means com­mit­tee on Wednes­day marked up leg­is­la­tion that would re­quire phar­ma­cy ben­e­fit man­agers to de-link their com­pen­sa­tion from the price of

Sanofi’s CSO and glob­al head of re­search Frank Nes­tle is leav­ing the com­pa­ny, a rep­re­sen­ta­tive con­firmed to End­points News Wednes­day. Nes­tle first took over both

(This sto­ry is from our new Health Tech newslet­ter. If you’d like to sign up, just click here.) For the first time in April, biosim­i­lars

Te­va is get­ting ready to close the first chap­ter of its “piv­ot to growth” strat­e­gy. The com­pa­ny’s re­struc­tur­ing has in­volved man­u­fac­tur­ing site clo­sures, a shift

FDA Com­mis­sion­er Rob Califf told the Sen­ate Ap­pro­pri­a­tions Com­mit­tee on Wednes­day that milk prod­ucts are safe from the H5N1 bird flu virus that’s cir­cu­lat­ing, and

BeiGene is build­ing a fourth fa­cil­i­ty in Chi­na with a bud­get of $74 mil­lion for the land and con­struc­tion. Ac­cord­ing to its first-quar­ter earn­ings in

Plus, news about Think Bio­science and Apel­lis: Pharm­ing ax­es Or­chard pact: The Dutch bio­phar­ma ter­mi­nat­ed a re­search col­lab­o­ra­tion and li­cens­ing agree­ment with Or­chard Ther­a­peu­tics due

Mar­i­nus Phar­ma­ceu­ti­cals is cut­ting about 20% of its work­force and mak­ing oth­er cost-cut­ting changes to ex­tend its cash run­way in­to the first quar­ter of 2025.

Google Deep­Mind and Iso­mor­phic Labs un­veiled the newest ver­sion of Al­phaFold, tak­ing its flag­ship AI mod­el far be­yond pre­dict­ing the struc­ture of a sin­gle pro­tein.